NeoGenomics operate a network of cancer-focused testing laboratories in the U.S., Europe and Asia. Co.'s testing services include the following: Cytogenetics (karyotype analysis), a study of chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization, a molecular cytogenetic technique that focuses on detecting and localizing the presence or absence of specific DNA sequences and genes on chromosomes; Flow cytometry, a technique utilized to measure the characteristics of cell populations; Immunohistochemistry and Digital Imaging; Molecular testing; and Morphologic analysis, a process of analyzing cells under the microscope. We show 59 historical shares outstanding datapoints in our NEO shares outstanding history coverage, used to compute NEO market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing NEO market cap history over the course of time is important for investors
interested in comparing NEO's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of NEO versus a peer is one thing; comparing
NEO market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like NEO can fluctuate over the course of history.
With this page we aim to empower investors researching NEO by allowing them to research the NEO market cap history. |
Free NEO Email Alerts:
Video: The Importance of Market Cap
